Urinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence

Neurourology and Urodynamics

Volumn 29, Issue 3, 2010, Pages 482-487

  Kuo, Hann Chorng ^a   Liu, Hsin Tzu ^a   Chancellor, Michael B ^b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Increased bladder sensation; Lower urinary tract symptoms; Nerve growth factor; Overactive bladder; Urodynamics

Indexed keywords

NERVE GROWTH FACTOR; BIOLOGICAL MARKER;

ARTICLE; BLADDER CAPACITY; BLADDER CATHETERIZATION; BLADDER FILLING; CLINICAL ASSESSMENT; COMPARATIVE STUDY; DETRUSOR MUSCLE; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MICTURITION; MORPHOMETRICS; OVERACTIVE BLADDER; STATISTICAL SIGNIFICANCE; URINALYSIS; URINE INCONTINENCE; URODYNAMICS; BLADDER; PATHOLOGY; URINE;

BIOLOGICAL MARKERS; FEMALE; HUMANS; NERVE GROWTH FACTOR; URINARY BLADDER; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE;

EID: 77953579275     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.20741     Document Type: Article

References (21)

1. Abrams P, Kelleher CJ, Kerr LA, et al. Overactive bladder significantly affects quality of life. Am J Manag Care 2000;6:S580-90.
2. Homma Y, Yoshida M, Seki N, et al. Symptom assessment tool for overactive bladder syndrome-Overactive bladder symptom score. Urology 2006;68: 318-323
3. Nixon A, Colman S, Sabounjian L, et al. Validated patient reportedmeasure of urinary urgency severity in overactive bladder for use in clinical trials. J Urol 2005;174:604-607
4. Steers WD, Tuttle JB. Mechanisms of diseases: The role of nerve growth factor in the pathophysiology of bladder disorders. Nat Clin Pract Urol 2006;3:101-110
5. Tuttle JB, Steers WD, Albo M, et al. Neural input regulates tissue NGF and growth of the adult urinary bladder. J Auton Nerv Syst 1994;49:147-158
6. Lowe EM, Anand P, Terenghi G, et al. Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol 1997;79:572-577
7. Liu HT, Kuo HC. Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment. Urology 2008;72:1056-1060
8. Kim JC, Park EY. Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder. J Urol 2006;175:1773-1776
9. Liu HT, Kuo HC. Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder. J Urol 2008;179:2270-2274
10. Liu HT, Chancellor MB, Kuo HC. Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection. Eur Urol 2008; Apr 30 [Epub ahead of print].
11. Liu HT, Kuo HC. Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention. Neurourol Urodynam 2009;28:78-81.
12. Lamb K, Gebhart GF, Bielefeldt K. Increased nerve growth factor expression triggers bladder overactivity. J Pain 2004;5:150-156
13. Oelke M, Hofner K, Jonas U, et al. Diagnostic accuracy of noninvasive tests to evaluate bladder outlet obstruction in men: Detrusor wall thickness, uroflowmetry, postvoid residual urine, and prostate volume. Eur Urol 2007;52:827-834
14. Kessler TM, Gerber R, Burkhard FC, et al. Ultrasound assessment of detrusor thickness in men: Can it predict bladder outlet obstruction and replace pressure flow study? J Urol 2006;175:2170-2173
15. Manieri C, Carter SS, Romano G, et al. The diagnosis of bladder outlet obstruction in men by ultrasound measurement of bladder wall thickness. J Urol 1998;159:761-765
16. Muller L, Bergstrom T, Hellstrom M, et al. Standardized ultrasound method for assessing detrusor muscle thickness in children. J Urol 2000;164:134-138
17. Blatt AH, Titus J, Chan L. Ultrasound measurement of bladder wall thickness in the assessment of voiding dysfunction. J Urol 2008;179:2275-2278
18. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: Report from the Standardisation Subcommittee of the International Continence Society. Neurourol Urodyn 2002;21:167-177
19. Kuo HC. Videourodynamic characteristics and lower urinary tract symptoms of female bladder outlet obstruction. Urology 2005;66:1005-1009
20. Liu HT, Kuo HC, Chancellor MB. The urinary nerve growth factor levels decrease with time in association with resolution of urgency severity after antimuscarinic therapy in patients with overactive bladder. BJU Int 2008; 102:1440-1444
21. Hashim H, Abrams P. In the bladder a reliablewitness for predicting detrusor overactivity? J Urol 2006;175:191-194